FSL constructs: A simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability

Journal of Visualized Experiments

Volumn , Issue 54, 2011, Pages

  Blake, Deborah A ^a   Bovin, Nicolai V ^b   Bess, Dan ^c   Henry, Stephen M ^a  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80355132654     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3289     Document Type: Article

References (14)

1. Waehler, R., Russell, S.J., & Curiel, D.T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 8, 573-587 (2007).
2. Strable, E., & Finn, M.G. Chemical modification of viruses and virus-like particles. Curr. Top. Microbiol. Immunol. 327, 1-21 (2009).
3. Henry, S., & Bovin, N. The development of synthetic peptidolipids, glycolipids and other lipid-linked structures to create designer red cells. Transfusion. 48 (2S) Suppl 194A, (2008).
4. Frame, T., Carroll, T., Korchagina, E., Bovin, N., & Henry, S. Synthetic glycolipid modification of red blood cell membranes. Transfusion. 47, 876-882 (2007).
5. Hult, A.K., Frame, T., Henry, S., & Olsson, M.L. Flow cytometry evaluation of red blood cells transformed with variable amounts of synthetic A and B glycolipids. Vox Sang. 95 (Suppl 1), 180 (2008).
6. Henry, S. Modification of red blood cells for laboratory quality control use. Curr. Opin. Hematol. 16 (6), 467-472 (2009).
7. Oliver, C., Blake, D., & Henry, S. In vivo neutralization of anti-A and successful transfusion of A antigen incompatible red cells in an animal model. in press Transfusion. doi: 10.1111/j.1537-2995.2011.03184.x (2011).
8. Oliver, C., Blake, D., & Henry, S. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion. doi:10.1111/j.1537-2995.2010.03034.x (In Press 2011).
9. Heathcote, D., Carroll, T., Wang, J.J., Flower, R., Rodionov, I., Tuzikov, A., Bovin, N., & Henry, S. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytes. Transfusion. 50, 635-641, (2010).
10. Hadac, E.M., Federspiel, M.J., Chernyy, E., Tuzikovb, A., Korchagina, E., Bovin, N.V., Russell, S.J., & Henry, S.M. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. J Virol Meth. doi:10.1016/j.jviromet.2011.06.005 (In Press 2011).
11. Blake, D., Lan, A., Love, D., Bovin, N., & Henry, S. Fluorophore-kodecytes - fluorescent function-spacer-lipid (FSL) modified cells for in vitro and in vivo analyses. FEBS J. 277 (Suppl. 1), 199, (2010).
12. Harrison, A.L., Olsson, M.L., Brad Jones, R., Ramkumar, S., Sakac, D., Binnington, B., Henry, S., Lingwood, C.A., & Branch, D.R. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycobiology. 27, 515-524 (2010).
13. Barr, K., Diegel, O., Parker, S., Bovin, N., & Henry, S. Function-Spacer-Lipid (FSL) constructs enable inkjet printing of blood group antigens. FEBS J. 277 (Suppl. 1), 235 (2010).
14. Lan, C-C. Modeling inflammatory bowel disease PhD Thesis, University of Auckland, (2011).